MedCity News November 26, 2024
Marissa Plescia

In this episode, we’re joined by Dr. Piraye Yurttas Beim, founder and CEO of Celmatix, a women’s health biotech company. She discusses the funding the company recently received through the Sprint for Women’s Health program.

Welcome back to another episode of MedCity FemFwd, a podcast dedicated to discussing the breakthroughs and challenges in women’s health. In this episode, we’re joined...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Conferences / Podcast, Investments, Pharma / Biotech, Trends
AbbVie Enters Obesity Field, Paying $350M for Amylin Receptor Agonist Already in the Clinic
2025 Drugs to Watch: Market Access, Innovation, and the Future of Reimbursement
Renowned Geneticist Francis Collins, MD, PhD, Retires from NIH
How AI Is Transforming The Pharmaceutical Industry
MHE Week in Review – Medicaid Cuts, Congressional PBM Hearing and More

Share This Article